AI 聊天
Loading data for PSIL — first visit, this takes a few seconds.

AdvisorShares Psychedelics ETF

PSIL · NYSEArca · USD

25.25 +0.66 (2.68%)

收盘价: Sep 14, 2026, 2:54 PM

市值
成交量
20.6K

AdvisorShares Psychedelics ETF(PSIL)股价、分析与数据

内在价值

正在加载内在价值…

分析师预测

股票预测 →

分析师预测不可用

12个月目标价 · n/a 位分析师

分析师一致意见: n/a

时间间隔:1D
正在加载K线和信号…

财务表现

查看财务 →

加载中...

最新财报

已公布较预期同比变动
营收n/an/a
每股收益(TTM)n/an/a

下次财报

查看财报详情 →

指标

买价
24.68
市值
n/a
净利润(TTM)
n/a
n/a
n/a
n/a
n/a
市净率(TTM)
n/a
市销率(TTM)
n/a
财报日期
n/a
卖价
24.84
成交量
20,573
20日均量
41,933
开盘价
24.81
前收盘价
24.59
日内区间
24.45 - 24.89
52周区间
15.63 - 27.02
分红
n/a
除息日
n/a

关于 AdvisorShares Psychedelics ETF

查看公司资料 →
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified. n/a · n/a

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

行业 n/a
板块 n/a
上市日期 Sep 16, 2021
员工人数 n/a
交易所 NYSEArca
股票代码 PSIL